Buys
Open market- Shares
- Avg price
- Total value
Amy Parison - SVP, Chief Financial Officer at Editas Medicine, Inc.
Issuer-level insider activity
- Role
- SVP, Chief Financial Officer
- Issuer ticker
- EDIT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Amy Parison in Editas Medicine, Inc.
Sells
Open market- Shares
- -2,535
- Avg price
- $2.42
- Total value
- -$6,142
Net
Past year- Shares
- -2,535
- Share %
- -100%
- Total value
- -$6,142
Reported holdings for Amy Parison in Editas Medicine, Inc.
Form 4 holding
SVP, Chief Financial Officer
Editas Medicine, Inc.
- Security class
- Common Stock
- Shares / value
- 14,292
- Estimated value
- $36,873
- Report date
- 03 Aug 2026
- Price
- $2.58
- Ownership
- Direct
Form 4 holding
SVP, Chief Financial Officer
Editas Medicine, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 292,856
- Estimated value
- Report date
- 12 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Amy Parison in Editas Medicine, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.